Welcome : Guest

CHOLESTEROL TESTING - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Cholesterol Testing in US$ Thousand. The report provides separate comprehensive analytics for Cholesterol Screening and Lab Testing Services for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 29 companies including many key and niche players such as -

Abbott Diagnostics, Inc.
AccuTech, LLC
Akers Biosciences, Inc.
Alere Inc.
Beckman Coulter, Inc.
Bio-Rad Laboratories, Inc.

Click here to request a full list of companies covered in the report...

Code: MCP-3403
Price: $4950
Companies: 29
Pages: 239
Date: September 2017
Market Data Tables: 105
  Status: * New Report



TABLE OF CONTENTS


  CHOLESTEROL TESTING (Complete Report) Pages : 239   | $4950

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   Cholesterol Testing – An Overview.....II-11$100
   Prevailing Scenario in the Global Healthcare Sector Favors Market Growth.....II-2
Increasing Healthcare Expenditure.....II-2
1$100
   Table 1: Healthcare Spending as a Percentage (%) of National GDP for Select Developed Nations (2014) (includes corresponding Graph/Chart).....II-3

Table 2: Healthcare Spending as a Percentage (%) of National GDP for Select Developing Nations (2014) (includes corresponding Graph/Chart).....II-3
1$350
   Table 3: Per-Capita Healthcare Expenditure in US$ for Select Countries/Regions (2014) (includes corresponding Graph/Chart).....II-4
Wider Availability of Healthcare & Diagnostics Services.....II-4
1$350
   Growing Health-Consciousness.....II-5
Lenience Towards Preventive Care.....II-5
1$100
   Developed Regions Remain Key Revenue Contributors.....II-6
Developing Economies Offer Significant Potential.....II-6
Key Factors Driving Demand for Healthcare Services in Developing Regions.....II-6
Growing Healthcare Awareness.....II-6
1$100
   Increased Access to Healthcare.....II-7
Proliferation of Medical Tourism.....II-7
1$100
   Competitive Scenario.....II-8
Cholesterol Screening Services – Market Structure.....II-8
Cholesterol Test Equipment Market – Leading Players.....II-8
Vendors Prioritize Collaborations.....II-8
1$100
   M&A Activity.....II-9
Select M&A Deals in the Global Cholesterol Diagnostics Market (2014-2017).....II-9
1$100
   Growing Prevalence of Cardiovascular Disease Steers Demand for Cholesterol
  Testing.....II-10
Global Menace of Cardiovascular Disease: Quick Facts.....II-10
1$100
   A Brief Overview of Select Cholesterol-Driven Cardiac Disorders.....II-11
Coronary Artery Disease.....II-11
Hyperlipidaemia.....II-11
CVD Statistics.....II-11
Table 4: Global Annual Medical Cost of CVD in US$ Billion (2010-2030) (includes corresponding Graph/Chart).....II-11
1$350
   Table 5: Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others (includes corresponding Graph/Chart).....II-12

Table 6: Fatalities in Low Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD; Cancer; Injury; HIV, TB & Malaria; Malnutrition; and Others (includes corresponding Graph/Chart).....II-12
1$350
   Table 7: Fatalities in Mid Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD; Cancer; Injury; HIV, TB & Malaria; Malnutrition; and Others (includes corresponding Graph/Chart).....II-13

Table 8: Fatalities in High Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD, Cancer, Injury, and Others (includes corresponding Graph/Chart).....II-13
1$350
   Risk of CVD in Obese People Underpins Cholesterol Testing Volumes.....II-14
Global Obesity Facts in a Nutshell.....II-14
1$100
   Table 9: Global Obesity Epidemic: Percentage of Overweight, Obese, and Severely Obese Adults for 2014 & 2025 (includes corresponding Graph/Chart).....II-15

Table 10: Severely Obese Population (in Thousands) Worldwide by Country: 2014 & 2025 (includes corresponding Graph/Chart).....II-15
1$350
   Cholesterol Screening Assumes Importance in Diabetes Care.....II-16 1$100
   Table 11: World Diabetes and Population Statistics (2015 & 2040) (includes corresponding Graph/Chart).....II-17

Table 12: Global Prevalence of Diabetes - Number of Adults Diagnosed with Diabetes (in Million) by Gender for 2015 & 2040 (includes corresponding Graph/Chart).....II-17
1$350
   Table 13: Worldwide Diabetes Prevalence (%) in Adults by Age Group and Gender (2015) (includes corresponding Graph/Chart).....II-18

Table 14: Number of Adults with Diagnosed Diabetes in Urban and Rural Areas (2015 & 2040) (In Million) (includes corresponding Graph/Chart).....II-18
1$350
   Table 15: Top 10 Countries with Highest Number of Adults Diagnosed with Diabetes (in Million) for 2015 & 2040 (includes corresponding Graph/Chart).....II-191$350
   The Hypertension-Cholesterol Link Accelerates the Need for Cholesterol
  Screening.....II-20
1$100
   Table 16: Hypertension Prevalence (%) Worldwide by Region in Male and Females Aged 25+ Years (includes corresponding Graph/Chart).....II-21

Table 17: Economic Burden of Cardiovascular Diseases between 2011 and 2025: Breakdown of Lost Output Value by Income Group (includes corresponding Graph/Chart).....II-21
1$350
   Table 18: Percentage of Hypertension-Associated Deaths in Various Non-Communicable Diseases (NCD) (includes corresponding Graph/Chart).....II-22
Aging Population – A Vital Demography.....II-22
1$350
   Table 19: Global Population Statistics for 65+ Age Group (Male & Female) for Major Countries/Regions (mid-2016) (includes corresponding Graph/Chart).....II-231$350
   Table 20: Global Life Expectancy at Age 60 and 80 Years - (2010-2015), (2020-2025) & (2045-2050) (includes corresponding Graph/Chart).....II-24
Uptrend in In-Vitro Diagnostics (IVD) Sector Signals Prospects.....II-24
1$350
   Table 21: Global In Vitro Diagnostics Market by Test Category (2017E): Percentage Breakdown of Value Sales for Anatomic Pathology, Blood Screen Immunoassay, Coagulation, Hematology, Immunoassay, Microbiology, Molecular Diagnostics, Point-of-Care Diagnostics, and Others (includes corresponding Graph/Chart).....II-251$350
   Table 22: Global In Vitro Diagnostics Market by Sector (2017E): Percentage Breakdown of Revenues for Decentralized & Patient Self-Testing, and Hospital & Commercial Laboratories (includes corresponding Graph/Chart).....II-26

Table 23: Global In Vitro Diagnostics Market by Geographic Region (2017E): Percentage Breakdown of Value Sales for the Asia-Pacific, Europe, Latin America, United States, and Rest of World (includes corresponding Graph/Chart).....II-26
Healthy Growth in Cardiac IVD Market Augments Market Potential.....II-26
1$350
   Positive Momentum in Point of Care (POC) Diagnostics Generates Parallel
  Opportunities.....II-27
POC Diagnostics – An Overview.....II-27
1$100
   Table 24: Global Point Of Care (POC) Diagnostics Market by Category (2017E): Percentage Breakdown of Revenues for Blood Gas Testing, Cardiac Markers, Cholesterol Screening, Coagulation Monitoring, Fertility/Pregnancy Testing, Glucose Monitoring, Hematology Testing, Infectious Diseases Testing and Others (includes corresponding Graph/Chart).....II-281$350
   Table 25: Global Point Of Care (POC) Diagnostics Market by End-Use Segment (2017E): Percentage Breakdown of Revenues for Clinics, Diagnostic Labs, Hospitals, Self Testing & Others (includes corresponding Graph/Chart).....II-29
POC Cholesterol Testing Makes Rapid Gains.....II-29
Massive Demand for Lipid Panel/Lipid Profile Tests.....II-29
1$350
   Northbound Trajectory in POC LPT Services.....II-301$100
   Rise of C-reactive Protein Tests to Aid Market Growth.....II-31
Cholesterol Testing: Evolution from Invasive to Non-Invasive.....II-31
Recent Breakthroughs in Non-Invasive Cholesterol Testing Domain.....II-31
Smartphone-based smartCARD Rapid Diagnostic System.....II-31
1$100
   Paper-Thin Miniature Sensors.....II-32
PreVu® POC Test with Skin Markers.....II-32
1$100
   Digital Photographs of Patient’s Hand to Screen Cholesterol.....II-33
Nonfasting Lipid Testing Invalidates the Need for Pre-Test Fasting.....II-33
1$100
   Cloud Screening Platforms Extend New Level of Convenience.....II-34
Self-Testing Kits: An Emerging Issue for Full-Scale Services Providers.....II-34
A Rapidly Evolving Market Enabled by Technology.....II-34
1$100
   Opportunities & Challenges in Self-Testing Industry.....II-35
E-Retailing Drives Sales of Home Test Kits.....II-35
Factors Influencing Online Purchase Decision - Ranked in Order of Influence.....II-35
1$100
   A Brief Overview of Select Cholesterol Test Kits.....II-36
Roche Diagnostics Accutrend® Plus system.....II-36
PTS CardioChek Analyzer Starter Kit.....II-36
PTS CardioChek Deluxe Cholesterol Kit.....II-36
PTS CardioChek Refill Cholesterol Kit.....II-36
AccuTech CholesTrak Home Cholesterol Test Kit 2 ea.....II-36
AccuTech Cholestrak Total Cholesterol Home Testing Kit.....II-36
1$100
   PRIMA Cholesterol & Triglycerides 2-in-1 Home Test/Meter Kit Monitoring
  System.....II-37
PRIMA Home Test 3-in-1 Cholesterol, Triglycerides & Glucose Complete Self
  Testing Kit.....II-37
EasyLife Cholesterol Test Strips.....II-37
Easylife Hemoglobin Cholesterol Glucose Test Meter Kit.....II-37
Solana Health Best Home Complete HDL, Lipid Panel LDL & Triglycerides Test
  Kit.....II-37
LifeSign DietMate Handheld Weight, Cholesterol, and Hypertension Control
  Computer.....II-37
1$100
   Blood Cholesterol – The Principal Cardiac Risk Marker.....II-38
Types of Cholesterol.....II-38
Total Cholesterol (TC).....II-38
High Density Lipoprotein (HDL).....II-38
Low Density Lipoprotein (LDL) / Very Low Density Lipoprotein (VLDL).....II-38
1$100
   Triglycerides (TRG).....II-39
Glucose (GLU).....II-39
Alanine Aminotransferase (ALT).....II-39
Outcomes of High Blood Cholesterol.....II-39
Atherosclerosis.....II-39
Coronary Heart Disease (CHD).....II-39
Risk Factors and Risk Levels.....II-39
Risk Factors.....II-39
1$100
   Risk Levels.....II-40
Risk Level Classification under National Heart, Lung and Blood Institute’s National
  Cholesterol Education Program (NCEP).....II-40
Risk Level Based on Total Cholesterol Concentration.....II-40
LDL-Cholesterol Risk Levels.....II-40
HDL-Cholesterol Risk Levels.....II-40
Triglyceride Risk Levels.....II-40
1$100
   Cholesterol Testing & CVD Risk Assessment Techniques.....II-41
Need for Cholesterol Testing.....II-41
Candidates for Cholesterol Testing.....II-41
1$100
   Test Procedure.....II-42
Time of Testing – Crucial for Heart Disease Patients.....II-42
1$100
   Types of Cholesterol Testing.....II-43
Lipid Panel Test/Lipid Profile.....II-43
Total Cholesterol Test.....II-43
1$100
   HDL Cholesterol Test.....II-44
LDL Cholesterol Testing.....II-44
LDL Cholesterol Test – The First Cholesterol Testing Method.....II-44
Triglycerides/VLDL Cholesterol Testing.....II-44
1$100
   Apolipoprotein B Test.....II-45
Apolipoprotein A-1 Test.....II-45
ApoE Genotyping Test.....II-45
Apolipoprotein CII.....II-45
Other Key Markers for Cholesterol Testing.....II-45
RLP Cholesterol.....II-45
1$100
   Non Instrumented Technologies.....II-46
Heart Disease Diagnosis Tests.....II-46
Non-Invasive Tests.....II-46
Invasive Tests.....II-46
1$100
   Other CVD Markers.....II-47
Creatin Kinase MB.....II-47
Troponin T and Troponin I.....II-47
1$100
   Myoglobin.....II-48
P-selectin Profile.....II-48
C-reactive Protein.....II-48
Endothelial Dysfunction.....II-48
Homocysteine.....II-48
1$100
   Plasminogen Activator Inhibitor-1.....II-49
s-100 Protein.....II-49
1$100
   Thrombus Precursor Protein.....II-50
Other Cardiac Markers.....II-50
Cholesterol Screening & Lab Testing Services Providers.....II-50
Cholesterol Control & Treatment Modalities.....II-50
1$100
   Dietary Therapy.....II-51
Healthy Diet.....II-51
Exercises.....II-51
1$100
   Drug Therapy.....II-52
Classification of Cholesterol Lowering Drugs.....II-52
Bile Acid Sequestrants.....II-52
Nicotinic Acid.....II-52
HMG CoA Reductase Inhibitors (Statins).....II-52
1$100
   Other Drugs (Fibric Acids and Probucol).....II-53
Testing After Commencing Drug Therapy.....II-53
1$100
   Quest Diagnostics Rolls Out Non-Fasting Cholesterol Tests.....II-54
VAP Diagnostics Lab Relaunches VAP+ Lipid Panel.....II-54
Bio-Rad Laboratories Unveils Bio-Plex Pro™ Human Apolipoprotein Panel.....II-54
Color Genomics Launches New Test for Hereditary High Cholesterol.....II-54
Admera Health Unveils New DNA Tests.....II-54
Mayo Clinic Launches Blood Test to Predict Adverse Cardiovascular Events Using Plasma
  Ceramides.....II-54
1$100
   PTS Diagnostics Rolls Out PTS Connect™ Wellness Solution.....II-551$100
   Abbott Laboratories to Acquire Alere.....II-56
Siemens Healthineers to Expand Massachusetts Facility.....II-56
PTS Bags USFDA Clearance for New Measurement Range for PTS Panels®.....II-56
Alere to Divest Triage Assets to Quidel.....II-56
Akers Biosciences Inks Distribution Agreement with First Check Diagnostics.....II-56
Merck to Split into Three Separate Businesses.....II-56
1$100
   Atonomics Receives CE Marking for Trace Lipids Test Panel.....II-57
Siemens Healthineers Partners with DiA Holding.....II-57
PTS Diagnostics Inks Distribution Agreement with Anda.....II-57
PTS Diagnostics Renews Multi-Year Agreement with Life Line Screening.....II-57
Siemens Healthcare Rebrands itself as Siemens Healthineers.....II-57
Sinocare Acquires PTS Diagnostics.....II-57
1$100
   Eurofins Snaps Up Boston Heart Diagnostics.....II-58
Merck Acquires Sigma-Aldrich.....II-58
Optum Snaps Up Alere Health from Alere.....II-58
PTS Diagnostics Collaborates with Blinded Diagnostics.....II-58
1$100
   Abbott Laboratories (USA).....II-59
AccuTech, LLC (USA).....II-59
1$100
   Akers Biosciences, Inc. (USA).....II-60
Alere Inc. (USA).....II-60
1$100
   Beckman Coulter, Inc. (USA).....II-611$100
   Bio-Rad Laboratories, Inc. (USA).....II-62
Eurofins Scientific (Luxembourg).....II-62
Boston Heart Diagnostics Corporation (USA).....II-62
1$100
   Home Access Health Corporation (USA).....II-63
Laboratory Corporation of America® Holdings (USA).....II-63
1$100
   PRIMA Lab SA (Switzerland).....II-64
PTS Diagnostics (USA).....II-64
Quest Diagnostics, Inc. (USA).....II-64
1$100
   Randox Laboratories Ltd. (UK).....II-65
Roche Diagnostics (USA).....II-65
1$100
   Sekisui Diagnostics, LLC (USA).....II-66
Siemens Healthineers (Germany).....II-66
1$100
   Sigma-Aldrich Corp. (USA).....II-671$100
   Table 26: World Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....II-681$350
   Table 27: World Historic Review for Cholesterol Screening and Lab Testing Services by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-691$350
   Table 28: World 14-Year Perspective for Cholesterol Screening and Lab Testing Services by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....II-701$350
   A. Market Analysis.....III-1
The United States: Largest Market for Cholesterol Screening Services.....III-1
Surge in CVD Incidence – Key Growth Driver.....III-1
CVD Incidence: Key Statistics.....III-1
1$75
   Table 29: CVD in the US: Cardiovascular Disease Prevalence in Adults by Gender & Age Group (includes corresponding Graph/Chart).....III-2

Table 30: CVD in the US: Cardiovascular Disease Incidence by Gender & Age Group (per 1,000 Adults) (includes corresponding Graph/Chart).....III-2
1$200
   Table 31: Leading Causes of CVD Fatalities in the US: Percentage Breakdown of Mortality for Coronary Heart Disease, HBP, Heart Failure, Stroke, and Others (includes corresponding Graph/Chart).....III-3
The Risk of CVD in Chronic Conditions Propels Testing Market.....III-3
Obesity.....III-3
1$200
   Table 32: Obesity Prevalence in US Adults by Type of Obesity (2015) (includes corresponding Graph/Chart).....III-4

Table 33: Obesity Prevalence in the US by Age Group (2015) (includes corresponding Graph/Chart).....III-4
1$200
   Table 34: Obesity Prevalence in the US by Percentage Annual Income Level of Adult Population (2015) (includes corresponding Graph/Chart).....III-5
Diabetes.....III-5
1$200
   Table 35: Diabetes Statistics in North America & Caribbean (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-61$200
   Table 36: Diabetes and Population Statistics in North America and Caribbean Region (2015 & 2040) (includes corresponding Graph/Chart).....III-7

Table 37: Diabetes Prevalence in the US (2015): Percentage Share of Number of Diabetics by Gender (includes corresponding Graph/Chart).....III-7

Table 38: Diabetes Prevalence in the US (2015): Percentage Share of Number of Diabetics by Age Group (includes corresponding Graph/Chart).....III-7
1$200
   Hypertension.....III-8
Table 39: High Blood Pressure Prevalence in the US by Gender (2016E) (includes corresponding Graph/Chart).....III-8
1$200
   Table 40: High Blood Pressure Prevalence in the US (2016E): Prevalence Rates for Male and Female Population by Age Groups (includes corresponding Graph/Chart).....III-9

Table 41: High Blood Pressure Prevalence in the US (2016E): Prevalence Rates for Male and Female Population by Ethnic Group (includes corresponding Graph/Chart).....III-9
1$200
   Ageing Population – Vital Demography.....III-10
Table 42: North American Elderly Population by Age Group: 1975-2050.....III-10
1$200
   Preventive Care Trend to Widen Growth.....III-11
Uptrend in Point of Care (POC) Diagnostics Enhances Market Prospects.....III-11
Cholesterol POC Testing Market: An Overview.....III-11
1$75
   Growing Popularity of Consumer Self Testing.....III-12
Expanding Role of HCPs Strengthens Self-Testing Market.....III-12
1$75
   Prospects & Challenges for Self-Testing Healthcare Devices Market.....III-131$75
   Regulatory Changes Support Self-Testing.....III-14
Increased Preference for Home Test Devices.....III-14
Cholesterol Test Kits Offered by Select Companies.....III-14
1$75
   Product/Service Launches.....III-151$75
   Strategic Corporate Developments.....III-161$75
   Key Players.....III-178$600
   B. Market Analytics.....III-25
Table 43: US Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-25
1$200
   Table 44: US Historic Review for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-261$200
   A. Market Analysis.....III-27
Growing Incidence of CVD & Lifestyle Diseases Augments Test Volumes.....III-27
Table 45: Adult Diabetes in Canada (2015): Percentage Share Breakdown of Diabetic Population by Gender (includes corresponding Graph/Chart).....III-27

Table 46: Adult Diabetes in Canada (2015): Percentage Share Breakdown of Diabetic Population by Age Group (includes corresponding Graph/Chart).....III-27
1$200
   B. Market Analytics.....III-28
Table 47: Canadian Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-28
1$200
   Table 48: Canadian Historic Review for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-291$200
   A. Market Analysis.....III-30
Outlook.....III-30
Aging Population: Key Market Driver.....III-30
Table 49: Japanese Elderly (65+ Years) Population: 2000-2020 (includes corresponding Graph/Chart).....III-30
1$200
   B. Market Analytics.....III-31
Table 50: Japanese Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-31
1$200
   Table 51: Japanese Historic Review for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-321$200
   A. Market Analysis.....III-33
Europe: The Second Major Market for Cholesterol Testing.....III-33
CVD Prevalence Steers Testing Volumes.....III-33
1$75
   Screening Children for Familial Hypercholesterolemia.....III-34
Higher Incidence of Obesity.....III-34
1$75
   Table 52: Obesity Prevalence as a Percentage (%) of National Population in Select European Countries (2016) (includes corresponding Graph/Chart).....III-35
Ageing Demography – An Opportunity Indicator.....III-35
1$200
   Table 53: Population Breakup by Age Group for Select European Countries: 2015 (as Percentage of Total Population) (includes corresponding Graph/Chart).....III-361$200
   EU-wide Campaigns to Prop Up Market Prospects.....III-371$75
   B. Market Analytics.....III-38
Table 54: European Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-38
1$200
   Table 55: European Historic Review for Cholesterol Screening and Lab Testing Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-391$200
   Table 56: European 14-Year Perspective for Cholesterol Screening and Lab Testing Services by Geographic Region - Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-401$200
   Market Analysis.....III-41
Table 57: French Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-41
1$200
   Table 58: French Historic Review for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-421$200
   A. Market Analysis.....III-43
Outlook.....III-43
German Healthcare System: A Review.....III-43
Table 59: Growth of Senior Citizen Population in Germany: 2000-2025 (includes corresponding Graph/Chart).....III-43
1$200
   Strategic Corporate Developments.....III-44
Key Player.....III-44
1$75
   B. Market Analytics.....III-45
Table 60: German Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-45
1$200
   Table 61: German Historic Review for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-461$200
   Market Analysis.....III-47
Table 62: Italian Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-47
1$200
   Table 63: Italian Historic Review for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-481$200
   A. Market Analysis.....III-49
Outlook.....III-49
Cholesterol Testing Assumes Importance Amid Rising Obesity Cases.....III-49
Enhanced Focus on Diabetes Management Drives Demand.....III-49
1$75
   Table 64: Number of Children with Type 1 Diabetes in Select Countries (2015) (includes corresponding Graph/Chart).....III-50
Key Player.....III-50
1$200
   B. Market Analytics.....III-51
Table 65: UK Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-51
1$200
   Table 66: UK Historic Review for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-521$200
   Market Analysis.....III-53
Table 67: Spanish Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-53
1$200
   Table 68: Spanish Historic Review for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-541$200
   Market Analysis.....III-55
Table 69: Russian Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-55
1$200
   Table 70: Russian Historic Review for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-561$200
   A. Market Analysis.....III-57
Outlook.....III-57
Strategic Corporate Developments.....III-57
Key Players.....III-57
1$75
   B. Market Analytics.....III-58
Table 71: Rest of Europe Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-58
1$200
   Table 72: Rest of Europe Historic Review for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-591$200
   A. Market Analysis.....III-60
Asia-Pacific: The Rapidly Growing Market for Cholesterol Testing Services.....III-60
Increasing Incidence of CVD Fuels Demand.....III-60
Growing Diabetic Population: A Business Case.....III-60
1$75
   Table 73: Diabetes and Population Statistics in Western Pacific (2015 & 2040) (includes corresponding Graph/Chart).....III-611$200
   Table 74: Diabetes Statistics in Western Pacific (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-621$200
   Table 75: Diabetes and Population Statistics in South East Asia (2015 & 2040) (includes corresponding Graph/Chart).....III-631$200
   Table 76: Diabetes Statistics in South East Asia (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-641$200
   B. Market Analytics.....III-65
Table 77: Asia-Pacific Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services by Geographic Region - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-65
1$200
   Table 78: Asia-Pacific Historic Review for Cholesterol Screening and Lab Testing Services by Geographic Region - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-661$200
   Table 79: Asia-Pacific 14-Year Perspective for Cholesterol Screening and Lab Testing Services by Geographic Region - Percentage Breakdown of Revenues for China, India, and Rest of Asia-Pacific Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-671$200
   A. Market Analysis.....III-68
Outlook.....III-68
Ongoing Expansion in the Domestic Healthcare Sector Bodes Well.....III-68
1$75
   Table 80: Healthcare Spending in China for years 2004, 2009 & 2014 (includes corresponding Graph/Chart).....III-69
Strategic Corporate Development.....III-69
1$200
   B. Market Analytics.....III-70
Table 81: Chinese Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-70
1$200
   Table 82: Chinese Historic Review for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-711$200
   A. Market Analysis.....III-72
Outlook.....III-72
Increasing Healthcare Expenditure Augments Market Prospects.....III-72
1$75
   B. Market Analytics.....III-73
Table 83: Indian Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-73
1$200
   Table 84: Indian Historic Review for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-741$200
   A. Market Analysis.....III-75
Outlook.....III-75
A Brief Overview of Diagnostics Sector In Select Regional Markets.....III-75
South Korea.....III-75
Malaysia.....III-75
Philippines.....III-75
1$75
   Singapore.....III-76
Indonesia.....III-76
Hong Kong.....III-76
1$75
   B. Market Analytics.....III-77
Table 85: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-77
1$200
   Table 86: Rest of Asia-Pacific Historic Review for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-781$200
   A. Market Analysis.....III-79
Outlook.....III-79
Growing Population of Diabetics & Aged People Enhances Demand.....III-79
1$75
   Table 87: Diabetes and Population Statistics in Central and South America (2015 & 2040) (includes corresponding Graph/Chart).....III-801$200
   Table 88: Diabetes Statistics in South & Central America (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-811$200
   Table 89: Aging Population in Latin America and the Caribbean by Region (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-821$200
   Table 90: Aging Population in Latin America by Country (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-831$200
   B. Market Analytics.....III-84
Table 91: Latin American Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services by Geographic Region - Brazil, and Rest of Latin America Markets Independently Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-84
1$200
   Table 92: Latin American Historic Review for Cholesterol Screening and Lab Testing Services by Geographic Region - Brazil, and Rest of Latin America Markets Independently Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-851$200
   Table 93: Latin American 14-Year Perspective for Cholesterol Screening and Lab Testing Services by Geographic Region - Percentage Breakdown of Revenues for Brazil, and Rest of Latin America Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-861$200
   Market Analysis.....III-87
Table 94: Brazilian Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-87
1$200
   Table 95: Brazilian Historic Review for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-881$200
   Market Analysis.....III-89
Table 96: Rest of Latin America Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-89
1$200
   Table 97: Rest of Latin America Historic Review for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-901$200
   A. Market Analysis.....III-91
Outlook.....III-91
Expanding Diabetic & Older Population Drive Demand for Cholesterol
  Screening.....III-91
Table 98: African Diabetes and Population Statistics (2015 & 2040) (includes corresponding Graph/Chart).....III-91
1$200
   Table 99: Diabetes Statistics in Africa (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-921$200
   Table 100: Diabetes and Population Statistics in Middle East and North Africa (2015 & 2040) (includes corresponding Graph/Chart).....III-931$200
   Table 101: Diabetes Statistics in Middle East and North Africa (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-941$200
   Table 102: Aging Population in the Middle East by Country (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-951$200
   Table 103: Aging Population in Africa by Region (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-961$200
   B. Market Analytics.....III-97
Table 104: Rest of World Recent Past, Current & Future Analysis for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-97
1$200
   Table 105: Rest of World Historic Review for Cholesterol Screening and Lab Testing Services Market Analyzed with Annual Revenues in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-981$200
  
Total Companies Profiled: 29

Region/Country Players

The United States 23 Canada 1 Japan 1 Europe 2 Germany 1 The United Kingdom 1 Asia-Pacific (Excluding Japan) 2
Click here to request a full table of contents and more details on this project.